Advanced search
Publication Cover
Journal of Asthma Volume 61, 2024 - Issue 1
Submit an article Journal homepage
195
Views
0
CrossRef citations to date
0
Altmetric
Case Reports

Long-term use of mepolizumab in a case of chronic eosinophilic pneumonia: extending interval dosing

Alicia Prieto-Garcíaa Allergy Service, Gregorio Marañón University Hospital, Gregorio Marañón Health Research Institute, Madrid, SpainCorrespondence[email protected]
View further author information
, MD, PhD,
María Isabel Peligrosb Pathology Department, Gregorio Marañón University Hospital, Gregorio Marañón Health Research Institute, Madrid, SpainView further author information
, MD,
Isabel Pérez Tamayoc Internal Medicine Department, Gregorio Marañón University Hospital, Gregorio Marañón Health Research Institute, Madrid, SpainView further author information
, MD,
José Manuel Zubeldiaa Allergy Service, Gregorio Marañón University Hospital, Gregorio Marañón Health Research Institute, Madrid, Spain;d Biomedical Research Network on Rare Diseases (CIBERER)-U761, Madrid, SpainView further author information
, MD, PhD,
Luis Álvarez-Salac Internal Medicine Department, Gregorio Marañón University Hospital, Gregorio Marañón Health Research Institute, Madrid, SpainView further author information
, MD, PhD &
Cristina Lavillac Internal Medicine Department, Gregorio Marañón University Hospital, Gregorio Marañón Health Research Institute, Madrid, SpainView further author information
, MD
Pages 69-71 | Received 25 May 2023, Accepted 17 Jul 2023, Published online: 23 Jul 2023

References

  • To M, Kono Y, Yamawaki S, Soeda S, Katsube O, Kishi H, To Y. A case of chronic eosinophilic pneumonia successfully treated with mepolizumab. J Allergy Clin Immunol Pract. 2018;6(5):1746–1748.e1. doi:10.1016/j.jaip.2018.06.017.
  • Sarkis E, Patel S, Burns K, Batarseh H, Mador MJ. Anti-interleukin (IL)-5 as a steroid-sparing agent in chronic eosinophilic pneumonia. J Asthma. 2020;57(1):82–86. doi:10.1080/02770903.2018.1543434.
  • Kisling A, Jones J, Hixson C, Hostler D, Hostler J. Mepolizumab: an alternative therapy for idiopathic chronic eosinophilic pneumonia with glucocorticoid intolerance. Drugs Context. 2020;9:2020-5-3.
  • Ciuffreda M, Caruso C, Romano A, Sarni A. Effect of mepolizumab alone in chronic eosinophilic pneumonia relapse: a case report. J Allergy Clin Immunol Pract. 2020;8(10):3640–3642. doi:10.1016/j.jaip.2020.06.053.
  • Brenard E, Pilette C, Dahlqvist C, Colinet B, Schleich F, Roufosse F, Froidure A. Real-life study of mepolizumab in idiopathic chronic eosinophilic pneumonia. Lung. 2020;198(2):355–360. doi:10.1007/s00408-020-00336-3.
  • Shimizu Y, Kurosawa M, Sutoh Y, Sutoh E. Long-term treatment with anti-interleukin 5 antibodies in a patient with chronic eosinophilic pneumonia. J Investig Allergol Clin Immunol. 2020;30(2):154–155. doi:10.18176/jiaci.0468.
  • Sato H, Miyata Y, Inoue H, Tanaka A, Sagara H. Efficacy of mepolizumab extended interval dosing for 2 asthmatic patients with chronic eosinophilic pneumonia. J Investig Allergol Clin Immunol. 2021;31(5):459–460. doi:10.18176/jiaci.0671.
  • Tashiro H, Takahashi K, Kurihara Y, Sadamatsu H, Kuwahara Y, Kimura S, Sueoka-Aragane N. Anti-IL-5 agents for the treatment of idiopathic chronic eosinophilic pneumonia: a case series. J Asthma Allergy. 2022;15:169–177. doi:10.2147/JAA.S343272.
  • Nishimori M, Tsunemine H, Maruoka H, Itoh K, Kodaka T, Matsuoka H, Takahashi T. Marked thrombocytosis in chronic eosinophilic pneumonia and analysis of cytokine mechanism. J Clin Exp Hematop. 2015;55(2):97–102.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.